FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

NCT04141995 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Due to low accrual and futility

Conditions

Pancreas Cancer
Adenocarcinoma of the Pancreas

Interventions

DRUG: Digoxin
DRUG: 5Fluorouracil
DRUG: Calcium Leucovorin
DRUG: Irinotecan
DRUG: Oxaliplatin

Sponsor

University of Nebraska

Collaborators

[object Object]